February 28, 2015 10:55 AM ET

Healthcare Equipment and Supplies

Company Overview of Angiotech Pharmaceuticals Inc.

Company Overview

Angiotech Pharmaceuticals, Inc. develops, manufactures, and markets medical device products and technologies primarily in the areas of interventional oncology, wound closure, and ophthalmology worldwide. The company’s Medical Device Technologies segment offers single use medical device products and precision manufactured medical device components. This segment’s products include BioPince full core biopsy devices for obtaining tissue samples from patients for analysis and diagnosis of disease; Tru-Core and SuperCore disposable biopsy instruments that are designed to address various diagnostic procedures; T-Lok bone marrow biopsy devices, which are used for collecting bone marrow; and SKATER d...

355 Burrard Street

Suite 1100

Vancouver, BC V6C 2G8

Canada

Founded in 1989

1,364 Employees

Phone:

604-221-7676

Fax:

604-221-2330

Key Executives for Angiotech Pharmaceuticals Inc.

Angiotech Pharmaceuticals Inc. does not have any Key Executives recorded.

Angiotech Pharmaceuticals Inc. Key Developments

K. Thomas Bailey Steps Down to Angiotech Pharmaceuticals Inc.'s Board of Directors

Angiotech Pharmaceuticals Inc. announced that K. Thomas Bailey has stepped down from the company's board of directors effective immediately.

Angiotech Pharmaceuticals, Inc. Appoints John R. Barr as Chief Executive Officer

Angiotech Pharmaceuticals Inc. announced that its Board of Directors has appointed John R. Barr as Chief Executive Officer. Mr. Barr brings over 35 years of medical device and operational leadership experience. Mr. Barr most recently served as Executive Vice President and President Global Surgical at Bausch + Lomb immediately prior to its acquisition by Valeant Pharmaceuticals in 2013.

Angiotech Pharmaceuticals, Inc. Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2013

Angiotech Pharmaceuticals Inc. reported financial results for the fourth quarter and full year ended December 31, 2013. For the year, the company reported product revenue of USD 128.8 million, an increase of 5% from USD 123.1 million recorded in 2012. The year-over-year improvement in sales was primarily driven by strong demand for its core suture lines and its microsurgical knives in the US and Asia and continued growth in the overall sales of its various knotless suture product lines. Royalty revenue for 2013 was USD 5.5 million, down 64% from USD 15.1 million recorded in 2012. Adjusted EBITDA for the year ended December 31, 2013 was USD 36.7 million, a reduction of 19% from USD 45.1 million recorded in 2012. For the quarter, the company’s product revenue was USD 30.2 million, down 6% from USD 32.1 million in the fourth quarter of 2012. Quarter-over-quarter results were impacted primarily by buying patterns of certain of its OEM and private label customers, including Ethicon, its sole private label customer for its knotless suture product lines, and competitive pressure in the U.S. for direct sales of Quill. Royalty revenue was USD 1.6 million, down 47% from USD 3.0 million in the fourth quarter of 2012. Compared to 2013, royalties were also down in both fourth quarter and the year in 2013 compared to last year due to a reversal of royalties earned in prior periods from Cook associated with their voluntary recall of Zilver PTX drug-eluting stents in April 2013. Adjusted EBITDA was USD 6.9 million, down 41% from USD 11.7 million in the fourth quarter of 2012.

Similar Private Companies By Industry

Company Name Region
Feedband Inc. Americas
Sybron Canada LP Americas
Imagin Diagnostic Centres, Inc. Americas
Immersion Canada Americas
CHG Hospital Beds, Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Angiotech Pharmaceuticals Inc., please visit www.angiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.